Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining <i>Helicobacter pylori</i> Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study

<div>Incidence of gastric neoplasm according to the groups. This figure shows Cox regression analysis for the incidence of gastric cancer and gastric adenoma according to the groups (classified by <i>H. pylori</i> antibody status and pepsinogen status).</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining <i>Helicobacter pylori</i> Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study 

Figure 2 | Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study 